# Yatharth Hospital & Trauma Care Services (NSE: YATHARTH) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/YATHARTH · Pivot · prices to 21 Oct 2026

Yatharth Hospital & Trauma Care Services (NSE: YATHARTH) closed at ₹939.30 on 21 Oct 2026. With a market capitalisation of ₹9,327 Cr, it ranks 578th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

At its last close the stock traded at 53.1× trailing earnings, against a return on equity of 9.7% in FY26. Over the past year the share price has risen 19.5%. Its 52-week range is ₹538.25 (27 Jan 2026) to ₹1,184.00 (18 Sep 2026); the last close is 20.7% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹342 Cr (+47.4% year on year) and net profit ₹45 Cr (+15.4%), on a consolidated basis. Promoters held 55.80% of the company as of 30 Jun 2026; 9.59% of promoter shares were pledged.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹939.30 |
| Market cap | ₹9,327 Cr |
| P/E (trailing) | 53.1 |
| ROE | 9.7% (FY26) |
| ROCE | 11.0% (FY26) |
| Debt to equity | 0.14 |
| 52-week high | ₹1,184.00 (18 Sep 2026) |
| 52-week low | ₹538.25 (27 Jan 2026) |
| 1-year return | +19.5% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹342 Cr | +47.4% | ₹45 Cr | +15.4% | ₹4.93 |
| Q3 FY26 | ₹320 Cr | +46.2% | ₹43 Cr | +41.3% | ₹4.71 |
| Q2 FY26 | ₹279 Cr | +28.3% | ₹41 Cr | +33.3% | ₹4.28 |
| Q1 FY26 | ₹258 Cr | +21.7% | ₹42 Cr | +38.4% | ₹4.36 |
| Q4 FY25 | ₹232 Cr | +30.4% | ₹39 Cr | +1.0% | ₹4.37 |
| Q3 FY25 | ₹219 Cr | +31.4% | ₹30 Cr | +3.4% | ₹3.57 |
| Q2 FY25 | ₹218 Cr | +27.1% | ₹31 Cr | +12.1% | ₹3.59 |
| Q1 FY25 | ₹212 Cr | +37.1% | ₹30 Cr | +59.6% | ₹3.54 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹880 Cr | ₹131 Cr |
| FY24 | ₹671 Cr | ₹114 Cr |
| FY23 | ₹520 Cr | ₹66 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 55.80%
- Foreign institutions: 5.62%
- Domestic institutions: 10.84%
- Non-institutions: 27.74%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Metropolis Healthcare](https://app.pivotnow.in/stock/METROPOLIS) | ₹512.60 | ₹10,628 Cr | 55.8 | — |
| [Park Medi World](https://app.pivotnow.in/stock/PARKHOSPS) | ₹228.50 | ₹9,870 Cr | 33.3 | — |
| [Viyash Scientific](https://app.pivotnow.in/stock/VIYASH) | ₹220.83 | ₹9,648 Cr | 55.1 | — |
| [Blue Jet Healthcare](https://app.pivotnow.in/stock/BLUEJET) | ₹508.00 | ₹9,615 Cr | 35.5 | — |
| [Strides Pharma Science](https://app.pivotnow.in/stock/STAR) | ₹1,019.90 | ₹9,401 Cr | 16.9 | — |
| [Healthcare Global Enterprises](https://app.pivotnow.in/stock/HCG) | ₹570.00 | ₹8,510 Cr | — | — |

## Questions and answers

### What is the share price of Yatharth Hospital & Trauma Care Services today?

Yatharth Hospital & Trauma Care Services (NSE: YATHARTH) last closed at ₹939.30 on 21 Oct 2026. Its 52-week high is ₹1,184.00 and its 52-week low is ₹538.25.

### What is the market cap of Yatharth Hospital & Trauma Care Services?

Yatharth Hospital & Trauma Care Services' market capitalisation is ₹9,327 Cr (₹9,327 Cr) at the 19 Oct 2026 close, ranking 578th among the NSE companies Pivot tracks.

### What is the P/E ratio of Yatharth Hospital & Trauma Care Services?

Yatharth Hospital & Trauma Care Services trades at a trailing P/E of 53.1. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 35.5.

### What is the ROE and ROCE of Yatharth Hospital & Trauma Care Services?

Return on equity was 9.7% in FY26 and return on capital employed was 11.0% in FY26 (consolidated figures).

### Is Yatharth Hospital & Trauma Care Services a debt-free company?

No. Yatharth Hospital & Trauma Care Services' debt-to-equity ratio was 0.14 in FY26, with total debt of ₹227 Cr.

### What were Yatharth Hospital & Trauma Care Services' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Yatharth Hospital & Trauma Care Services reported revenue of ₹342 Cr, +47.4% year on year, and net profit of ₹45 Cr, +15.4% year on year.

### How has Yatharth Hospital & Trauma Care Services stock performed over the last year?

Yatharth Hospital & Trauma Care Services' share price has risen 19.5% over the past year, +13.5% over three months and −10.1% over one month, to the 19 Oct 2026 close.

### What is the shareholding pattern of Yatharth Hospital & Trauma Care Services?

As of 30 Jun 2026: promoters 55.80%, foreign institutions 5.62%, domestic institutions 10.84%, non-institutions 27.74%. 9.59% of promoter shares were pledged.

### Who are Yatharth Hospital & Trauma Care Services' competitors?

The listed Pharma & Healthcare companies closest to Yatharth Hospital & Trauma Care Services by market cap are Metropolis Healthcare, Park Medi World, Viyash Scientific, Blue Jet Healthcare, Strides Pharma Science and Healthcare Global Enterprises.

### Is Yatharth Hospital & Trauma Care Services a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Yatharth Hospital & Trauma Care Services' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on YATHARTH against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.